Educational guide
PNC-27 Dosage Protocol | PeptideDosages.com
PNC-27 (30 mg Vial) Dosage Protocol PNC-27 (30 mg Vial) Dosage Protocol PNC-27 Dosage Chart PNC-27 is dosed at 100 mcg–500 mcg daily via subcutaneous injection in educational protocols. A 30 mg vial reconstituted with bacteriostatic water yields about 10 mg/mL
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
PNC-27 (30 mg Vial) Dosage Protocol
PNC-27 (30 mg Vial) Dosage Protocol
PNC-27 Dosage Chart
PNC-27 is dosed at 100 mcg–500 mcg daily via subcutaneous injection in educational protocols. A 30 mg vial reconstituted with bacteriostatic water yields about 10 mg/mL. This information is for research and educational use only.
Reconstitute: Add 3.0 mL bacteriostatic water → 10 mg/mL concentration.
Typical daily range: 100–500 mcg once daily (gradual titration).
Easy measuring: At 10 mg/mL, 1 unit = 0.01 mL = 100 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
PNC-27 is a synthetic 32‑amino‑acid peptide containing an HDM‑2‑binding domain linked to a membrane‑penetrating sequence, studied preclinically for its selective cytotoxicity toward cancer cells expressing abnormal p53/HDM‑2 complexes[1][2]. No human clinical trials exist, and the FDA explicitly warns that PNC-27 products are unapproved and lack established safety data[3]. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read PNC-27 Peptide: Benefits, Uses, Side Effects, Dosage, and Research.
Standard / Gradual Approach (3 mL = 10 mg/mL)
Weeks 1–2
100 mcg (0.10 mg)
1 unit (0.01 mL)
Weeks 3–4
200 mcg (0.20 mg)
2 units (0.02 mL)
Weeks 5–8
300 mcg (0.30 mg)
3 units (0.03 mL)
Weeks 9–12
400 mcg (0.40 mg)
4 units (0.04 mL)
Weeks 13–16
500 mcg (0.50 mg)
5 units (0.05 mL)
Frequency: Inject once daily subcutaneously. For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.
Critical Note: No authoritative human dosing exists for PNC-27. The FDA warns that PNC-27 safety has not been established[3]. Any dosing above a few hundred micrograms per day is purely speculative[4].
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Supplies Needed
Plan based on an 8–16 week daily protocol with gradual titration.
Peptide Vials (PNC-27, 30 mg each):
8 weeks ≈ 1 vial (~15–20 mg total used)
12 weeks ≈ 1 vial (~25 mg total used)
16 weeks ≈ 2 vials (~35–40 mg total used)
Insulin Syringes (U‑100 or 30/50‑unit for precision):
Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
8 weeks (1 vial): 3 mL → 1 × 10 mL bottle
12 weeks (1 vial): 3 mL → 1 × 10 mL bottle
16 weeks (2 vials): 6 mL → 1 × 10 mL bottle
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100‑count boxes
12 weeks: 168 swabs → recommend 2 × 100‑count boxes
16 weeks: 224 swabs → recommend 3 × 100‑count boxes